© 2019 International Society for Neurochemistry Treatment with the dopamine (DA) precursor l-3,4-dihydroxyphenylalanine (l-DOPA) provides symptomatic relief arising from DA denervation in Parkinson's disease. Mounting evidence that DA autooxidation to neurotoxic quinones is involved in Parkinson's disease pathogenesis has raised concern about potentiation of oxidative stress by l-DOPA. The rate of DA quinone formation increases in the presence of excess redox-active iron (Fe), which is a pathological hallmark of Parkinson's disease. Conversely, l-DOPA has pH-dependent Fe-chelating properties, and may act to ‘redox silence’ Fe and partially allay DA autoxidation. We examined the effects of l-DOPA in three murine models of parkinsonian neurod...
An urgent need for efficacious disease modifying therapies is required to slow downParkinson’s disea...
precursor of other neurotransmitters. Degeneration of nigrostriatal neurons of substantia nigra pars...
Research on Parkinson's disease has led to new hypotheses concerning the mechanisms of neurodegenera...
© 2007 - 2018 Frontiers Media S.A. Parkinson's disease is the second most common neurodegenerative d...
Parkinson's disease is the second most common neurodegenerative disease. While age is the most signi...
The role of dopamine as a vulnerability factor and a toxic agent in Parkinson’s disease (PD) is stil...
For 50 years ago was introduced L-3,4-dihydroxyphenylalanine (L-dopa) in Parkinson's disease treatme...
© 2016 The Author (2016). Published by Oxford University Press on behalf of the Guarantors of Brain....
Recent findings of impaired mitochondrial function, altered iron metabolism and increased lipid pero...
Environmental influences affecting genetically susceptible individuals seem to contribute significan...
© 2017, Medknow Publications. All rights reserved. For 50 years ago was introduced L-3,4-dihydroxyph...
About 60 years ago, the discovery of a deficiency of dopamine in the nigro-striatal system led to a ...
Of the documented cases of Parkinson's disease (PD), about 10% have a genetic background. The remain...
The transcription factor Nrf2 (NF-E2-related factor 2) and its target gene products, including heme ...
There is consensus that amelioration of the motor symptoms of Parkinson's disease is most effective ...
An urgent need for efficacious disease modifying therapies is required to slow downParkinson’s disea...
precursor of other neurotransmitters. Degeneration of nigrostriatal neurons of substantia nigra pars...
Research on Parkinson's disease has led to new hypotheses concerning the mechanisms of neurodegenera...
© 2007 - 2018 Frontiers Media S.A. Parkinson's disease is the second most common neurodegenerative d...
Parkinson's disease is the second most common neurodegenerative disease. While age is the most signi...
The role of dopamine as a vulnerability factor and a toxic agent in Parkinson’s disease (PD) is stil...
For 50 years ago was introduced L-3,4-dihydroxyphenylalanine (L-dopa) in Parkinson's disease treatme...
© 2016 The Author (2016). Published by Oxford University Press on behalf of the Guarantors of Brain....
Recent findings of impaired mitochondrial function, altered iron metabolism and increased lipid pero...
Environmental influences affecting genetically susceptible individuals seem to contribute significan...
© 2017, Medknow Publications. All rights reserved. For 50 years ago was introduced L-3,4-dihydroxyph...
About 60 years ago, the discovery of a deficiency of dopamine in the nigro-striatal system led to a ...
Of the documented cases of Parkinson's disease (PD), about 10% have a genetic background. The remain...
The transcription factor Nrf2 (NF-E2-related factor 2) and its target gene products, including heme ...
There is consensus that amelioration of the motor symptoms of Parkinson's disease is most effective ...
An urgent need for efficacious disease modifying therapies is required to slow downParkinson’s disea...
precursor of other neurotransmitters. Degeneration of nigrostriatal neurons of substantia nigra pars...
Research on Parkinson's disease has led to new hypotheses concerning the mechanisms of neurodegenera...